Provectus gains patent for medical image enhancer:
This article was originally published in Clinica
Executive Summary
Provectus Pharmaceuticals has gained a US patent covering its signal encoding and processing methods that it claims can significantly increase the sensitivity of imaging systems used in biomedical research. The methods, which can enhance the performance of a variety of microscopy systems, improve the sensitivity of the imaging systems and their ability to reject "spurious interference", claims the Knoxville, Tennessee firm.